Moderna, Inc. (0QF.F)

EUR 24.0

(-2.24%)

Total Debt Summary of Moderna, Inc.

Moderna, Inc.'s latest annual total debt in 2023 was 1.24 Billion USD , up 3.58% from previous year.
Moderna, Inc.'s latest quarterly total debt in 2024 Q2 was 1.26 Billion USD , up 2.59% from previous quarter.
Moderna, Inc. reported annual total debt of 1.2 Billion USD in 2022, up 31.0% from previous year.
Moderna, Inc. reported annual total debt of 916 Million USD in 2021, up 341.88% from previous year.
Moderna, Inc. reported quarterly total debt of 1.26 Billion USD for 2024 Q2, up 2.59% from previous quarter.
Moderna, Inc. reported quarterly total debt of 927 Million USD for 2023 Q1, down -22.75% from previous quarter.

Annual Total Debt Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Total Debt of Moderna, Inc. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	1.24 Billion USD	3.58%
2022	1.2 Billion USD	31.0%
2021	916 Million USD	341.88%
2020	207.29 Million USD	56.61%
2019	132.36 Million USD	295.25%
2018	33.48 Million USD	113.48%
2017	15.68 Million USD	25.5%
2016	12.5 Million USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	1.23 Billion USD	-0.48%
2024 Q2	1.26 Billion USD	2.59%
2023 Q1	927 Million USD	-22.75%
2023 Q3	1.27 Billion USD	34.32%
2023 Q2	947 Million USD	2.16%
2023 FY	1.24 Billion USD	3.58%
2023 Q4	1.24 Billion USD	-2.28%
2022 Q4	1.2 Billion USD	-4.84%
2022 Q3	1.26 Billion USD	42.16%
2022 Q2	887 Million USD	-6.34%
2022 FY	1.2 Billion USD	31.0%
2022 Q1	947 Million USD	3.38%
2021 Q1	234 Million USD	12.88%
2021 Q3	583 Million USD	-3.32%
2021 Q4	916 Million USD	57.12%
2021 FY	916 Million USD	341.88%
2021 Q2	603 Million USD	157.69%
2020 Q4	207.29 Million USD	-2.35%
2020 Q2	167.77 Million USD	13.48%
2020 Q1	147.84 Million USD	11.7%
2020 FY	207.29 Million USD	56.61%
2020 Q3	212.29 Million USD	26.54%
2019 Q2	33.58 Million USD	0.61%
2019 FY	132.36 Million USD	295.25%
2019 Q4	132.36 Million USD	291.6%
2019 Q3	33.8 Million USD	0.63%
2019 Q1	33.38 Million USD	-0.31%
2018 Q3	26.89 Million USD	0.0%
2018 FY	33.48 Million USD	113.48%
2018 Q4	33.48 Million USD	24.53%
2017 Q4	15.68 Million USD	0.0%
2017 FY	15.68 Million USD	25.5%
2016 FY	12.5 Million USD	0.0%

Peer Total Debt Comparison of Moderna, Inc.

Name	Total Debt	Total Debt Difference
BioNTech SE	219.1 Million EUR	-467.321%
CureVac N.V.	41.85 Million EUR	-2869.53%
Biotest Aktiengesellschaft	689.8 Million EUR	-80.197%
Biotest Aktiengesellschaft	689.8 Million EUR	-80.197%
BRAIN Biotech AG	4.65 Million EUR	-26579.545%
Formycon AG	29.48 Million EUR	-4115.56%
Heidelberg Pharma AG	5.83 Million EUR	-21215.716%
Medigene AG	2.95 Million EUR	-42035.593%